Sarafidis P - Search Results

1

Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.

Sarafidis P, Agarwal R, Pitt B, Wanner C, Filippatos G, Boletis J, Tuttle KR, Ruilope LM, Rossing P, Toto R, Anker SD, Liu ZH, Joseph A, Ahlers C, Brinker M, Lawatscheck R, Bakris G; FIDELIO-DKD and FIGARO-DKD Investigators. Sarafidis P, et al. Clin J Am Soc Nephrol. 2023 Mar 17;18(5):602-12. doi: 10.2215/CJN.0000000000000149. Online ahead of print. Clin J Am Soc Nephrol. 2023. PMID: 36927680 Free PMC article.

2

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.

Sarafidis PA, Ruilope LM. Sarafidis PA, et al. Am J Nephrol. 2006;26(3):232-44. doi: 10.1159/000093632. Epub 2006 May 29. Am J Nephrol. 2006. PMID: 16733348 Review.

3

Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.

Sarafidis PA, Bakris GL. Sarafidis PA, et al. QJM. 2006 Jul;99(7):431-6. doi: 10.1093/qjmed/hcl059. Epub 2006 Jun 9. QJM. 2006. PMID: 16766516 Review.

4

Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease.

Sarafidis PA, Bakris GL. Sarafidis PA, et al. Nephrol Dial Transplant. 2006 Sep;21(9):2366-74. doi: 10.1093/ndt/gfl309. Epub 2006 Jun 17. Nephrol Dial Transplant. 2006. PMID: 16782993 Review. No abstract available.

5

Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.

Sarafidis PA, Bakris GL. Sarafidis PA, et al. Kidney Int. 2006 Oct;70(7):1223-33. doi: 10.1038/sj.ki.5001620. Epub 2006 Aug 2. Kidney Int. 2006. PMID: 16883325 Free article. Review.

6

Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.

Sarafidis PA, McFarlane SI, Bakris GL. Sarafidis PA, et al. Curr Diab Rep. 2006 Jun;6(3):219-24. doi: 10.1007/s11892-006-0038-3. Curr Diab Rep. 2006. PMID: 16898575 Review.

7

Microalbuminuria.

Khosla N, Sarafidis PA, Bakris GL. Khosla N, et al. Clin Lab Med. 2006 Sep;26(3):635-53, vi-vii. doi: 10.1016/j.cll.2006.06.005. Clin Lab Med. 2006. PMID: 16938588 Review.

8

Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?

Sarafidis PA, Bakris GL. Sarafidis PA, et al. J Hum Hypertens. 2007 Jan;21(1):12-9. doi: 10.1038/sj.jhh.1002103. Epub 2006 Oct 19. J Hum Hypertens. 2007. PMID: 17051236 Review.

9

Review: Insulin and endothelin: an interplay contributing to hypertension development?

Sarafidis PA, Bakris GL. Sarafidis PA, et al. J Clin Endocrinol Metab. 2007 Feb;92(2):379-85. doi: 10.1210/jc.2006-1819. Epub 2006 Nov 21. J Clin Endocrinol Metab. 2007. PMID: 17118997 Review.

10

Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.

Sarafidis PA, Bakris GL. Sarafidis PA, et al. J Hypertens. 2007 Jan;25(1):249-52; author reply 252-3. doi: 10.1097/HJH.0b013e3280104fa5. J Hypertens. 2007. PMID: 17143201 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page